Abstract

Abstract Objectives Cystic lesions are relatively common in the pancreas, with pseudocysts accounting for 75% to 90% among other etiologies. In contrast to cysts in other organs, cysts in the pancreas are more likely to be neoplastic rather than benign or insignificant. EUS-guided FNA has served as a minimally invasive and fast diagnosis methodology. However, the efficacy of FNA on pancreatic lesions is controversial. Methods A 10-year retrospective study of upper EUS-guided FNA specimens on all cystic lesions in pancreas was conducted at the pathology department of a university hospital. Diagnoses and patient demographics were obtained. The frequency of diagnosis was investigated. When available, the endoscopic findings and CEA levels were obtained for analysis. Results A total of 188 pancreatic cyst FNA cases were collected. Approximately 80% of the specimens were satisfactory for cytology evaluation, and the diagnosis of “negative for dysplasia/malignancy” accounted for the majority of the cases (77.6%). The presence of communication with the pancreatic duct or elevated CEA level (>192 ng/mL) does not change the frequency of negative diagnosis significantly (P = .25). Among the 29 cases with a benign impression on EUS, only 1 case was upgraded to a higher lesion on cytology (3.5%) and this cyst measured >3 cm. Among 86 cysts ≤3 cm, only 1 case was diagnosed as an IPMN and high-grade dysplasia was not identified. All 41 cases with unsatisfactory cytology were due to insufficient cellularity, including 14 cases with an impression of a questionable lesion on EUS. Conclusion In our patient population, EUS-guided FNA of pancreatic cysts does not add significant diagnostic value to EUS findings of benign-appearing pancreatic cysts ≤3 cm and may not be cost-effective overall. Additional molecular testing on cyst fluid obtained by EUS-FNA, especially on cases with insufficient cellularity, may enhance the value of this minimally invasive procedure and improve its diagnostic performance.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call